dr. o'regan on emerging cdk4/6 combinations in breast cancer
Published 4 years ago • 62 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:42
dr. o'regan on biomarkers of response to cdk4/6 inhibitors in breast cancer
-
1:17
dr. o’regan on the utility of cdk4/6 inhibitors in breast cancer
-
1:47
dr. tripathy on combination strategies with cdk4/6 inhibitors in breast cancer
-
1:10
dr. o'regan on future of chemotherapy in breast cancer
-
1:21
dr. tripathy on combination strategies with cdk4/6 inhibitors in hr breast cancer
-
1:01
dr. o’regan on biosimilar education in breast cancer
-
6:36
adjuvant cdk4/6 inhibition in early-stage hr-positive breast cancer | ruth o'regan
-
1:23
dr. o'regan on endocrine therapy resistance in breast cancer
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
0:49
dr. o'regan on biomarker research in breast cancer
-
9:18
clinical experience: cdk4/6 inhibitors in breast cancer
-
1:21
dr. o'regan on treatment of breast cancer in premenopausal women
-
18:07
emerging evidence on the role of cdk4/6 inhibitors in early bc
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
3:50
cdk4/6 inhibitors in metastatic breast cancer
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
18:25
dr. o'regan on breast cancer treatment considerations during the covid-19 crisis
-
1:22
dr. rugo on resistance to cdk4/6 inhibitors in hr breast cancer
-
1:48
dr. novik on cdk4/6 inhibitor combinations in breast cancer